Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Zurich
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient must have extensive liver tumors that would require portal vein embolization or a two-stage hepatectomy and portal vein embolization or ligation by the judgment of surgeons in the tumor board.
Patient may have extrahepatic disease as long as it may be addressed after liver surgery and there is a tumor board decision to proceed with liver resection (mostly applicable to CRC metastases).
Patient may have received previous chemotherapy.
In cases of cholestasis, preoperative drainage procedures (PTC or ERCP) are left up to judgement of physicians.
Patient must be = 18 years of age. The patient population over 65 years old needs to be carefully included based on comorbidities.
Patient may have undergone previous liver resection.
Patient's location must be such that proper staging and follow-up may be performed.
Patient's case must be presented at the Multidisciplinary Meeting attended by hepatobiliary surgeons, oncologists, hepatologists, and radiologists, or must be approved directly by Dr. Strasberg or Dr. Chapman.
You may not be if
Patient must not have enrolled into a clinical trial within 4 weeks of study entry.
Patient must not have peritoneal carcinomatosis or other extensive extrahepatic disease.
Patient must not have advanced stages of carcinoma of the gallbladder (T3/T4)
Patient must not have issues such as drug and/or alcohol abuse.
Patient must not need major extrahepatic surgery (e.g. pancreas resection, gastric resection, rectal surgery) within 3 months of study entry.
Patient must not be a candidate for liver transplantation in case of HCC.
Patient must not be pregnant or breastfeeding. If a female of childbearing potential, patient must have a negative pregnancy test within 14 days of enrollment.
Clareo Health | ALLPS VERSUS PVO Randomized Controlled Trial
